{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T17:24:54Z","timestamp":1768325094586,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.biopsych.2006.09.036","type":"journal-article","created":{"date-parts":[[2007,1,9]],"date-time":"2007-01-09T18:39:38Z","timestamp":1168367978000},"page":"226-234","source":"Crossref","is-referenced-by-count":22,"title":["Risperidone and Cognitive Function in Children With Disruptive Behavior Disorders"],"prefix":"10.1016","volume":"62","author":[{"given":"Gahan J.","family":"Pandina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Bilder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip D.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard S.E.","family":"Keefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Aman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"Gharabawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2006.09.036_bib1","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1176\/appi.ajp.159.8.1337","article-title":"Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence","volume":"159","author":"Aman","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.036_bib2","first-page":"485","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"Am J Ment Defic"},{"key":"10.1016\/j.biopsych.2006.09.036_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0891-4222(95)00039-9","article-title":"The Nisonger CBRF: a child behavior rating form for children with developmental disabilities","volume":"17","author":"Aman","year":"1996","journal-title":"Res Dev Disabil"},{"key":"10.1016\/j.biopsych.2006.09.036_bib4","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"key":"10.1016\/j.biopsych.2006.09.036_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/393256","article-title":"The evolution of ADHD: a disorder of communication?","volume":"75","author":"Baird","year":"2000","journal-title":"Q Rev Biol"},{"key":"10.1016\/j.biopsych.2006.09.036_bib6","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00004583-200211000-00009","article-title":"Oppositional defiant disorder and conduct disorder: a review of the past 10 years, part II","volume":"41","author":"Burke","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.036_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.chi.0000145805.24274.09","article-title":"Risperidone in children with disruptive behavior disorders and subaverage intelligence: a one-year, open-label study of 504 patients","volume":"44","author":"Croonenberghs","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.036_bib8","series-title":"CVLT-C: California Verbal Learning Test\u2013Children\u2019s Version","author":"Delis","year":"1994"},{"key":"10.1016\/j.biopsych.2006.09.036_bib9","series-title":"Peabody Picture Vocabulary Test\u2013Third Edition","author":"Dunn","year":"1997"},{"key":"10.1016\/j.biopsych.2006.09.036_bib10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1176\/appi.ajp.161.4.677","article-title":"Long-term open-label study of risperidone in children with severe disruptive behaviors and subaverage intelligence","volume":"161","author":"Findling","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.036_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/oxfordjournals.schbul.a033430","article-title":"Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the \u201cright stuff\u201d?","volume":"26","author":"Green","year":"2000","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2006.09.036_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00213-002-1342-5","article-title":"Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study","volume":"169","author":"Harvey","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2006.09.036_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1176\/appi.ajp.158.2.176","article-title":"Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment","volume":"158","author":"Harvey","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.036_bib14","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/gps.929","article-title":"Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder","volume":"18","author":"Harvey","year":"2003","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.036_bib15","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1176\/appi.ajp.162.10.1888","article-title":"Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial","volume":"162","author":"Harvey","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.036_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2006.09.036_bib17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archpsyc.1977.01770170081007","article-title":"Sustained attention in children at risk for schizophrenia","volume":"34","author":"Rutschmann","year":"1977","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.036_bib18","doi-asserted-by":"crossref","first-page":"e634","DOI":"10.1542\/peds.2003-0264-F","article-title":"Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders","volume":"114","author":"Shea","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.biopsych.2006.09.036_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1037\/0096-3445.117.1.34","article-title":"Pragmatics of measuring recognition memory: Applications to dementia and amnesia","volume":"117","author":"Snodgrass","year":"1988","journal-title":"J Exp Psychol"},{"key":"10.1016\/j.biopsych.2006.09.036_bib20","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00004583-200209000-00002","article-title":"Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs","volume":"41","author":"Snyder","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2006.09.036_bib21","series-title":"Vineland Adaptive Behavior Scales","author":"Sparrow","year":"1984"},{"key":"10.1016\/j.biopsych.2006.09.036_bib22","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1542\/peds.110.3.e34","article-title":"Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs","volume":"110","author":"Turgay","year":"2002","journal-title":"Pediatrics"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322306012753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322306012753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T05:27:57Z","timestamp":1547098077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322306012753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0006322306012753"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2006.09.036","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}